ANESTHETIC, ANALGETIC, HYPNOTIC – ARE THE TERMS IMPORTANT?
https://doi.org/10.21292/2078-5658-2015-12-5-3-11
Abstract
The review is devoted to pharmacology of the general anesthesia in the light of current understanding of this event and as a medical technique. The discussion covers the classification of medications used for general anesthesia basing on action mechanisms of these substances including specific and nonspecific actions on the central nervous system functions and evolution of their presentation.
About the Authors
A. E. KarelovRussian Federation
K. M. Lebedinskiy
Russian Federation
V. I. Buravtsov
Russian Federation
References
1. Balandin V.V., Gorobets E.S. The first experience of opiod¬free anesthesia/ analgesia based on dexmedetomidinum for oncologic surgeries on head and neck in patients with «difficult respiratory tract’. Vestnik Anasteziol. i Reanimatol., 2013, vol. 10, no. 5, pp. 9¬13. (In Russ.)
2. Gottlieb R., Meyer H. H. Eksperimental’naya farmakologiya, kak osnova lekarstvennogo lecheniya. Rukovodstvo dlya vrachey i studentov. (Russ. Ed.: Gottlieb R., Meyer H. H. Pharmacology: Clinical And Experimental). Translated from German by P.V. Vaks and A.F. Drzhevetsky. St. Petersburg, Prakticheskaya Meditsina Publ., 1913, 557 p.
3. Grebenchikov O.А., Kozlova E.M., Mironenko А.V. et al. Minimum alveolar concentration of inhalation anesthetics. Vestnik Anasteziol. i Reanimatol., 2012, vol. 9, no. 1, pp. 48¬52. (In Russ.)
4. Zhorov I.S. Obschee obezbolivanie v khirurgii. Rukovodstvo dlya anesteziologov i khirurgov. [General anesthesia in surgery. Guidelines for anesthesiologists and surgeons]. Moscow, Medgiz Publ., 1959. 486 p.
5. Crick B. Mysli o mozge. (Russ. Ed.: F. Crick. Thinking about the brain). Ed. by P.V. Simonov. Moscow, Mir Publ., 1982. pp. 252¬278.
6. Lebedinskiy K.M. Trends in current anesthesiology development: research, practice and teaching. III s»ezd anesteziologov i reanimatologov Severo-Zapada Rossii. Sb. tezisov i dokladov. [IIIrd Conference of Anesthesiologists and Emergency Physicians of the North¬West of Russia. Coll. of abstracts and reports]. St. Petersburg, 2005, pp. 19¬31. (In Russ.)
7. Likhvantsev V.V. Reduction of intra¬surgery consumption of narcotic analgesics: Is the goal absolute and does always the end justify the means? Vestnik Anasteziol. i Reanimatol., 2012, vol. 9, no. 5, pp. 3¬5. (In Russ.)
8. Peruansky M., Piers R.A., Hemmings H.S.J. Ingalyatsionnye anestetiki: mekhanizmy deystviya V kn.: Аnesteziya Ronal’da Millera. (Russ. Ed.: Peruan¬sky M., Piers R.A., Hemmings H.S.J. Inhalation anesthetics: action mechanisms. In Miller’s Anesthesia). Transl. and ed. by K.M. Lebedinsky. St. Petersburg, Chelovek Publ., 2014, vol. 1, pp. 555¬581.
9. Prakticheskoe rukovodstvo po anesteziologii. [Practical guidelines on anesthesiology]. 2nd ed., Edited by V.V. Likhvantsev, Moscow, OOO Meditsinskoye Informatsionnoye Agentstvo Publ., 2011, 552 p.
10. Prigogine I., Stengers I. Poryadok iz khaosa. Novy dialog cheloveka s prirodoy. (Russ. Ed.: Prigogine, Ilya; Stengers, Isabelle. Order out of Chaos: Man’s new dialogue with nature). Ed. by V.I. Аrshinov, Yu.L. Klimontovich and Yu.V. Sachkov. Moscow, Progress Publ., 1986, 432 p.
11. Haken G. Sinergetika: Ierarkhii neustoychivostey v samoorganizuyuschikhsya sistemakh i ustroystvakh. (Russ. ed.: Haken G. The science of structure: synergetics). Moscow, Mir Publ., 1985, 423 p.
12. Abe K. Vasodilators during cerebral aneurysm surgery. Can. J. Anesth., 1993, vol. 40, pp. 775¬790.
13. Aho M., Erkola O., Kallio A. et al. Dexmedetomidine infusion for maintenance of anesthesia in patients undergoing abdominal hysterectomy. Anesth. Analg., 1992, vol. 75, no. 6, pp. 940¬946.
14. Barnard E.A., Skolnick P., Olsen R.W. et al. International Union of Pharmacology. XV. Subtypes of gamma¬aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev., 1998, vol. 50, pp. 291¬313.
15. Bekker A.Y., Kaufman B., Samir H. et al. The use of dexmedetomidine infusion for awake craniotomy. Anesth. Analg., 2001, vol. 92, pp. 1251¬1253.
16. Bennett J.A., Mahadeviah A., Stewart J. et al. Desflurane controls the hemo-dynamic response to surgical stimulation more rapidly than isoflurane. J. Clin. Anesth., 1995, vol. 7, pp. 288¬291.
17. Bonin R.P., Orser B.A. GABA¬A receptor subtypes underlying general anesthesia. Pharmacol. Biochem. Behav., 2008, vol. 90, pp. 105¬112.
18. Camerino D.C., Tricarico D., Desaphy J.¬F. Ion channel pharmacology. Neuro-therapeutics, 2007, vol. 4, pp. 184¬198.
19. Dalens B. Médicaments en anesthésie. 3ème édition. Wolters Kluwer France, 2013. 881 p.
20. 20, Eger E.I.II, Eisenkraft J.B., Weiskopf R.B. The Pharmacology of Inhaled Anesthetics. Distinguished Professor Program, 2002. pp. 34.
21. Engelhard K., Werner C. Narkose – Ihnalations¬ und Injectionsanästhetika. In: Aktories K., Förstermann U., Hofmann F., Starke K. Allgemeine und spezielle Pharmakologie und Toxikologie. München: Urban & Fisher, 2013, pp. 241¬260.
22. Franks N.P. Molecular targets underlying general anesthesia. Br. J. Pharmacol., 2006, vol. 147, (Suppl. 1), pp. S72¬S81.
23. Franks N.P., Dickinson R., de Sousa S.L. et al. How does xenon produce anaesthesia? Nature, 1998, vol. 396, pp. 324
24. Huotari M., Kukkonen K., Liikka N. et al. Effects of histamine H(3)¬ ligands on the levodopa¬induced turning behavior of hemiparkinsonian rats. Parkinsonism Relat Disord., 2000, vol. 6, no. 3, pp. 159¬164.
25. International Association for the Study of Pain. Classification of chronic pain: description of chronic pain syndromes and definitions of pain terms. Task force on taxonomy. suppl. 3, p. S217. Seattle: IASP Press, 1994.
26. Jerath A., Beattie S.W., Chandy T. et al. Volatile¬based short¬term sedation in cardiac surgical patients: a prospective randomized controlled trial. Crit. Care Med., 2015, vol. 43, no. 5, pp. 1062¬1069.
27. Jevtovic¬Todorovic V., Todorovic S.M., Mennerick S. et al. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat. Med., 1998, vol. 4, pp. 460¬463.
28. Kapur S., Seeman P. Ketamine has equal affinity for NMDA receptors and the high¬affinity state of the dopamine D2 receptor. Biol. Psychiatry, 2001, vol. 49, pp. 954¬957.
29. Kelly R.E., Lien C.A., Savarese J.J. et al. Depression of neuromuscular function in a patient during desflurane anesthesia. Anesth. Analg., 1993, vol. 76, pp. 868¬871.
30. Kissin I. General anesthetic action: an obsolete notion? Anesth. Analg., 1993, vol. 76, pp. 215¬218.
31. Lerou J.G. Nomogram to estimate age¬related MAC. Br. J. Anaesth., 2004, vol. 93, no. 2, pp. 288¬291.
32. Leslie J.B. Incidence and aetiology of perioperative hypertension. Acta Anaesth. Scand., 1993, vol. 99, suppl. pp. 5¬9.
33. Liang Z., Wang Y., Sun X. et al. EEG entropy measures in anesthesia. Front Comput Neurosci. 2015, vol. 9, pp. 1¬17.
34. Ludewig R., Regenthal R. Akute Vergiftungen und Arzneimittelüberdosierungen. 11te aufl. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 2014. 897 p.
35. Lutz H. Anästhesiologische Praxis. Berlin: Springer, 1986, 690 p.
36. Mantz J. Dexmedetomidine. Drugs Today (Barc)., 1999, vol. 35, no. 3, pp. 151-157.
37. Melzack R., Casey K.L. Sensory, motivational, and central control determinants of pain. In: The skin senses. Ed. D. R. Kenshalo. Springfield, IL: C. C.Thomas, 1968, pp. 423¬439.
38. Michaels R.L., Rothman S.M. Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations. J. Neurosci., 1990, vol. 10, no. 1, pp. 283¬292.
39. Pabelick C.M., Prakash Y.S., Kannan M.S. et al. Effects of halothane on sarcoplasmic reticulum calcium release channels in porcine airway smooth muscle cells. Anesthesiology, 2001, vol. 95, pp. 207¬215.
40. Patel A.J., Honore E., Lesage F. et al. Inhalational anesthestics activate two-pore¬domain background K+ chanels. Nat. Neurosci., 1999, vol. 2, pp. 422¬426.
41. Patel P.M., Patel H.H., Roth D.M. General Anesthetics and Therapeutic Gases. In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 12th ed. Ed. by L. L. Brunton, B. A. Chabner, B. C. Knollmann. New York, McGraw Hill Medical, 2011, pp. 527¬564.
42. Pertovaara A., Haapalinna A., Sirviö J. et al. Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2¬adrenoceptor antagonist. CNS Drug Rev., 2005, vol. 11, no. 3, pp. 273¬288.
43. Rampil I.J., Laster M.J., Eger E.I.II. Ondansetron does not alter isoflurane MAC in rats. Anesthesiology, 2001, vol. 95, pp. 562¬564.
44. Roberts M.C., Mickelson J.R., Patterson E.E. et al. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology, 2001, vol. 95, pp. 716¬725.
45. Rudolph U., Antkowiak B. Molecular and neuronal substrates of general anesthesia. Nat. Rev. Neurosci., 2004, vol. 5, pp. 709¬720.
46. Sokhal N., Rath G.P., Chaturvedi A. et al. Anaesthesia for awake craniotomy: A retrospective study of 54 cases. Indian J. Anaesth., 2015, vol. 59, no. 5, pp. 300-305.
47. Solt K., Stevens R.J., Davies P.A. et al. General anesthetic¬induced channel gating enhancement of 5¬hydroxytryptamine type 3 receptors depends on receptor subunit composition. J. Pharmacol. Exp. Ther., 2005, vol. 315, pp. 771¬776.
48. Thiel H., Roewer N. Anästhesiologische pharmakotherapie. Stuttgart – New York: Georg Thieme Verlag, 2014, pp. 122¬159.
49. Xu J., Jin C., Cui X. et al. Comparison of dexmedetomidine versus propofol for sedation after uvulopalatopharyngoplasty. Med. Sci. Monit., 2015, vol. 21, pp. 2125¬2133.
50. Yang Y.C., Lee C.H., Kuo C.C. Ionic flow enhances low¬affinity binding: a revised mechanistic view into Mg2+ block of NMDA receptors. J. Physiol., 2010, vol. 588, pp. 633¬650.
Review
For citations:
Karelov A.E., Lebedinskiy K.M., Buravtsov V.I. ANESTHETIC, ANALGETIC, HYPNOTIC – ARE THE TERMS IMPORTANT? Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2015;12(5):3-11. (In Russ.) https://doi.org/10.21292/2078-5658-2015-12-5-3-11